Varamir
Desk
News
Calendar
Pricing
Saved
Search
tickers or companies
⌘K
Start free
· no card
Sign in
HALO compared with EVR: revenue, margins and what each company keeps, and the suppliers and customers both name
HALO
Halozyme Therapeutics, Inc.
Change
Mkt cap
Revenue
Revenue
EVR
Evercore Inc.
Change
Mkt cap
Revenue
Revenue
vs
Compare
HALO
Halozyme Therapeutics, Inc.
vs
EVR
Evercore Inc.
Price
Mkt cap
Revenue
Revenue
Change
Change
Revenue flow
Supply chain
Price
Co-movers
Event sensitivity
Earnings history
Save comparison
Copy link
Price
Desk
News
Calendar
Saved
Search
Price
rebased to 0%
1D
1W
1M
3M
YTD
1Y
5Y
1D
1W
1M
3M
YTD
1Y
5Y
HALO, solid
EVR, dashed
HALO
Halozyme Therapeutics, Inc.
Change
128.93
· pre 129.09
· delayed
Mkt cap
$14.9B
Revenue
$481M
Q2 FY26
Revenue
$1.4B
FY25
EVR
Evercore Inc.
Change
302.05
· pre 303.28
· delayed
Pre-market
Nov 2 '26
delayed
Mkt cap
$11.2B
Revenue
$2.9B
Q2 FY26
Revenue
$11.5B
FY25
vs
Compare
Pre-market
Nov 2 '26
delayed
HALO
Halozyme Therapeutics, Inc.
vs
EVR
Evercore Inc.
128.93
pre 129.09
delayed
Price
302.05
pre 303.28
delayed
$14.9B
Mkt cap
$11.2B
Q2 FY26
$481M
Revenue
$2.9B
Q2 FY26
FY25
$1.4B
Revenue
$11.5B
FY25
Change
Change
HALO
128.93
vs
EVR
302.05
Pre-market
Nov 2 '26
delayed